Journal
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 96, Issue -, Pages 93-98Publisher
ELSEVIER
DOI: 10.1016/j.ejps.2016.09.010
Keywords
Extracellular vesicles; Exosomes; Biomarkers; Body fluids; Early diagnosis; Follow-up; Prostate cancer
Categories
Funding
- STSM bursary from the EU COST Action [BM1202]
Ask authors/readers for more resources
Despite considerable research efforts, the finding of reliable tumor biomarkers remains challenging and unresolved. In recent years a novel diagnostic biomedical tool with high potential has been identified in extracellular nanovesicles or exosomes. They are released by the majority of the cells and contain detailed molecular information on the cell of origin including tumor hallmarks. Exosomes can be isolated from easy accessible body fluids, and most importantly, they can provide several biomarkers, with different levels of specificity. Recent clinical evidence shows that the levels of exosomes released into body fluids may themselves represent a predictive/diagnostic of tumors, discriminating cancer patients from healthy subjects. The aim of this review is to highlight these latest challenging findings to provide novel and ground breaking ideas for successful tumor early diagnosis and follow-up. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available